IP Library › Patent Application 63494500
Patent Application Provisional
App. No. 63/494,500 · Confirmation No. 6142

Combination Therapy Comprising SIRP Alpha Fusion Protein and Anti-CD19 Antibody for Treatment of Cancer

Applicant: Pfizer Inc.
Provisional Application Expired
⬇ PDF
 Code Description Pages PDF
2023-05-25 N570 Communication - Re: Power of Attorney (PTOL-308) 1 View
2023-05-15 PA.. Power of Attorney 2 View
2023-05-15 N417 Electronic Filing System Acknowledgment Receipt 2 View
2023-04-14 APP.FILE.REC Filing Receipt 3 View
2023-04-06 CRFE Sequence Listing in Computer Readable Format, No errors found — View
2023-04-06 SPEC Specification 31 View
2023-04-06 CLM Claims 6 View
2023-04-06 ABST Abstract 1 View
2023-04-06 DRW Drawings-only black and white line drawings 1 View
2023-04-06 N417.PYMT Electronic Fee Payment 2 View
2023-04-06 ADS Application Data Sheet 10 View
2023-04-06 N417 Electronic Filing System Acknowledgment Receipt 2 View
2023-04-06 SEQ.XML Sequence Listing (XML File) 1 View
2023-04-06 CRFE Sequence Listing in Computer Readable Format, No errors found 14 View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
63/494,500
Filed
2023-04-06